Categories assigned to this post:

⭒ New Developments

$2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia

In response to the recent $2.2 billion settlement with Johnson and Johnson for mismarketing the antipsychotic drug Risperdal for elderly people with dementia, CANHR and other long term care consumer advocates released the following statement.

Read More…